Matt Abernethy Neurocrine Biosciences Inc (NBIX) insider trading activity

NBIX Quotes by TradingView

Matt Abernethy is Chief Financial Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 31,528 shares of NBIX, which is worth approximately $3.97 Million. The most recent transaction as insider was on Aug 13, 2024, when has been sold 14,100 shares (Common Stock) at a price of $150.38 per share, resulting in proceeds of $2,120,358. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.5K
0% 3M change
16.21% 12M change
Total Value Held $3.97 Million

MATT ABERNETHY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 13 2024
SELL
Open market or private sale
$2,120,358 $150.38 p/Share
14,100 Reduced 30.9%
31,528 Common Stock
Aug 13 2024
BUY
Exercise of conversion of derivative security
$1,037,759 $73.6 p/Share
14,100 Added 23.61%
45,628 Common Stock
Jul 16 2024
SELL
Open market or private sale
$135,036 $150.04 p/Share
900 Reduced 2.78%
31,528 Common Stock
Jul 16 2024
BUY
Exercise of conversion of derivative security
$66,240 $73.6 p/Share
900 Added 2.7%
32,428 Common Stock
May 15 2024
SELL
Open market or private sale
$2,103,600 $140.24 p/Share
15,000 Reduced 32.24%
31,528 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
$1,104,000 $73.6 p/Share
15,000 Added 24.38%
46,528 Common Stock
May 14 2024
SELL
Open market or private sale
$2,034,900 $135.66 p/Share
15,000 Reduced 32.24%
31,528 Common Stock
May 14 2024
BUY
Exercise of conversion of derivative security
$1,104,000 $73.6 p/Share
15,000 Added 24.38%
46,528 Common Stock
Feb 13 2024
SELL
Open market or private sale
$179,613 $132.85 p/Share
1,352 Reduced 4.11%
31,528 Common Stock
Feb 08 2024
SELL
Open market or private sale
$131,525 $134.21 p/Share
980 Reduced 3.13%
30,314 Common Stock
Feb 06 2024
SELL
Open market or private sale
$182,003 $142.19 p/Share
1,280 Reduced 4.17%
29,434 Common Stock
Jan 31 2024
SELL
Open market or private sale
$180,543 $140.72 p/Share
1,283 Reduced 4.34%
28,284 Common Stock
Aug 21 2023
SELL
Open market or private sale
$228,955 $107.39 p/Share
2,132 Reduced 7.29%
27,131 Common Stock
Feb 08 2023
SELL
Open market or private sale
$102,106 $104.19 p/Share
980 Reduced 3.74%
25,213 Common Stock
Feb 07 2023
SELL
Open market or private sale
$2,695,460 $102.38 p/Share
26,328 Reduced 51.97%
24,333 Common Stock
Feb 06 2023
SELL
Open market or private sale
$135,257 $105.67 p/Share
1,280 Reduced 5.38%
22,507 Common Stock
Jan 31 2023
SELL
Open market or private sale
$141,104 $109.98 p/Share
1,283 Reduced 5.67%
21,357 Common Stock
Feb 08 2022
SELL
Open market or private sale
$78,057 $79.65 p/Share
980 Reduced 4.63%
20,204 Common Stock
Feb 07 2022
SELL
Open market or private sale
$267,415 $80.79 p/Share
3,310 Reduced 14.62%
19,325 Common Stock
Dec 01 2021
SELL
Open market or private sale
$135,861 $82.59 p/Share
1,645 Reduced 9.14%
16,349 Common Stock
Feb 08 2021
SELL
Open market or private sale
$339,975 $116.83 p/Share
2,910 Reduced 16.37%
14,869 Common Stock
Dec 01 2020
SELL
Open market or private sale
$155,716 $94.66 p/Share
1,645 Reduced 12.52%
11,494 Common Stock
Nov 12 2020
SELL
Open market or private sale
$204,800 $90.74 p/Share
2,257 Reduced 18.39%
10,014 Common Stock
MA

Matt Abernethy

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBIX